Sun Pharmaceutical Industries Ltd.

In bid to expand its basket of specialty products to boost sales, Sun Pharmaceutical has bid to acquire US based eye care company InSite Vision Inc. The pact may be valued at around Rs 300 crore.

Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. The company provides high quality, affordable medicines trusted by healthcare professionals and patients in over 150 countries worldwide.